S&P 500   5,095.41 (-0.02%)
DOW   38,857.24 (-0.36%)
QQQ   440.63 (+0.37%)
AAPL   180.19 (-0.31%)
MSFT   414.22 (+0.14%)
META   497.48 (+1.50%)
GOOGL   138.26 (-0.14%)
AMZN   176.81 (+0.03%)
TSLA   199.04 (-1.41%)
NVDA   800.15 (+1.14%)
NIO   5.71 (-0.70%)
AMD   198.27 (+2.98%)
BABA   75.00 (+1.31%)
T   16.86 (-0.41%)
F   12.38 (-0.48%)
MU   93.48 (+3.17%)
CGC   3.25 (-1.22%)
GE   157.48 (+0.38%)
DIS   111.34 (-0.22%)
AMC   4.26 (-1.39%)
PFE   26.80 (+0.90%)
PYPL   60.67 (+0.55%)
XOM   106.09 (+1.50%)
S&P 500   5,095.41 (-0.02%)
DOW   38,857.24 (-0.36%)
QQQ   440.63 (+0.37%)
AAPL   180.19 (-0.31%)
MSFT   414.22 (+0.14%)
META   497.48 (+1.50%)
GOOGL   138.26 (-0.14%)
AMZN   176.81 (+0.03%)
TSLA   199.04 (-1.41%)
NVDA   800.15 (+1.14%)
NIO   5.71 (-0.70%)
AMD   198.27 (+2.98%)
BABA   75.00 (+1.31%)
T   16.86 (-0.41%)
F   12.38 (-0.48%)
MU   93.48 (+3.17%)
CGC   3.25 (-1.22%)
GE   157.48 (+0.38%)
DIS   111.34 (-0.22%)
AMC   4.26 (-1.39%)
PFE   26.80 (+0.90%)
PYPL   60.67 (+0.55%)
XOM   106.09 (+1.50%)
S&P 500   5,095.41 (-0.02%)
DOW   38,857.24 (-0.36%)
QQQ   440.63 (+0.37%)
AAPL   180.19 (-0.31%)
MSFT   414.22 (+0.14%)
META   497.48 (+1.50%)
GOOGL   138.26 (-0.14%)
AMZN   176.81 (+0.03%)
TSLA   199.04 (-1.41%)
NVDA   800.15 (+1.14%)
NIO   5.71 (-0.70%)
AMD   198.27 (+2.98%)
BABA   75.00 (+1.31%)
T   16.86 (-0.41%)
F   12.38 (-0.48%)
MU   93.48 (+3.17%)
CGC   3.25 (-1.22%)
GE   157.48 (+0.38%)
DIS   111.34 (-0.22%)
AMC   4.26 (-1.39%)
PFE   26.80 (+0.90%)
PYPL   60.67 (+0.55%)
XOM   106.09 (+1.50%)
S&P 500   5,095.41 (-0.02%)
DOW   38,857.24 (-0.36%)
QQQ   440.63 (+0.37%)
AAPL   180.19 (-0.31%)
MSFT   414.22 (+0.14%)
META   497.48 (+1.50%)
GOOGL   138.26 (-0.14%)
AMZN   176.81 (+0.03%)
TSLA   199.04 (-1.41%)
NVDA   800.15 (+1.14%)
NIO   5.71 (-0.70%)
AMD   198.27 (+2.98%)
BABA   75.00 (+1.31%)
T   16.86 (-0.41%)
F   12.38 (-0.48%)
MU   93.48 (+3.17%)
CGC   3.25 (-1.22%)
GE   157.48 (+0.38%)
DIS   111.34 (-0.22%)
AMC   4.26 (-1.39%)
PFE   26.80 (+0.90%)
PYPL   60.67 (+0.55%)
XOM   106.09 (+1.50%)

DocuSign (DOCU) Stock Price, News & Analysis

$53.66
+0.39 (+0.73%)
(As of 09:40 AM ET)
Today's Range
$52.90
$53.67
50-Day Range
$49.98
$63.55
52-Week Range
$38.11
$66.98
Volume
128,097 shs
Average Volume
3.74 million shs
Market Capitalization
$10.94 billion
P/E Ratio
214.65
Dividend Yield
N/A
Price Target
$60.00

DocuSign MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
12.6% Upside
$60.00 Price Target
Short Interest
Healthy
2.32% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.68
Upright™ Environmental Score
News Sentiment
0.95mentions of DocuSign in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$8.34 M Sold Last Quarter
Proj. Earnings Growth
-12.28%
From $0.57 to $0.50 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.35 out of 5 stars

Business Services Sector

45th out of 315 stocks

Prepackaged Software Industry

26th out of 206 stocks


DOCU stock logo

About DocuSign Stock (NASDAQ:DOCU)

DocuSign, Inc. provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce. It also provides Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; and Monitor that uses advanced analytics to track DocuSign eSignature web, mobile, and API account. In addition, the company offers Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally; DocuSign Federal and DocuSign CLM are FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct and partner-assisted sales, and web-based self-service purchasing. The company was incorporated in 2003 and is headquartered in San Francisco, California.

DOCU Stock Price History

DOCU Stock News Headlines

Analysts boosted Snowflake stock, big firms are buying now
Business services stocks like Snowflake could be the ones to see the next wave of investment inflows on the back of a heating labor market in the United States
3 large caps with RSIs that scream 'oversold'
Despite a soft start to the year, it's looking like stocks have their mojo back and are continuing to build on the upward momentum that started last quarter. All the key indices are back to all-time highs in an astonishing recovery rally that Wall Street is still getting to grips with.
Revolutionary Device Redefines Cancer Detection
Discover the breakthrough device that could transform the lives of the estimated 68 million Americans affected by skin cancer. Achieving unprecedented accuracy, this device identifies cancer's molecular signature in just 1.5 seconds. This innovation marks a rapid advance in the battle against cancer. See how investors are unlocking 10% in bonus shares for a limited time.
3 large caps with RSIs that scream 'oversold' (DOCU)
Considering how strong equities are performing right now, individual stocks that are trending down instead of up are worth watching closely.
DocuSign (DOCU) to Release Quarterly Earnings on Thursday
DocuSign: Why I Will Not Invest At Current Moment
The Return Trends At DocuSign (NASDAQ:DOCU) Look Promising
Revolutionary Device Redefines Cancer Detection
Discover the breakthrough device that could transform the lives of the estimated 68 million Americans affected by skin cancer. Achieving unprecedented accuracy, this device identifies cancer's molecular signature in just 1.5 seconds. This innovation marks a rapid advance in the battle against cancer. See how investors are unlocking 10% in bonus shares for a limited time.
Is Now the Time to Buy DocuSign Stock?
DOCU Mar 2024 70.000 call
DOCU Mar 2024 45.000 put
DOCU Mar 2024 50.000 call
DocuSign Stock: A Tale of Two Clouds
DocuSign Stock: A Tale of Two Clouds
DocuSign (DOCU) Stock Moves -0.48%: What You Should Know
3 Cloud Stocks to Buy for Multibagger Gains This Decade
Could DocuSign Become the Next Adobe?
Why Shares of DocuSign Slumped This Week
Why Shares of DocuSign Slumped This Week
See More Headlines
Receive DOCU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocuSign and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/07/2023
Today
2/29/2024
Next Earnings (Confirmed)
3/07/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:DOCU
Fax
N/A
Employees
7,336
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$60.00
High Stock Price Target
$87.00
Low Stock Price Target
$42.00
Potential Upside/Downside
+12.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
12 Analysts

Profitability

Net Income
$-97,450,000.00
Pretax Margin
2.56%

Debt

Sales & Book Value

Annual Sales
$2.52 billion
Cash Flow
$1.20 per share
Book Value
$3.07 per share

Miscellaneous

Free Float
167,634,000
Market Cap
$10.86 billion
Optionable
Optionable
Beta
0.93
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report














DOCU Stock Analysis - Frequently Asked Questions

Should I buy or sell DocuSign stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DocuSign in the last twelve months. There are currently 3 sell ratings, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DOCU shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCU, but not buy additional shares or sell existing shares.
View DOCU analyst ratings
or view top-rated stocks.

What is DocuSign's stock price target for 2024?

12 equities research analysts have issued 12-month price targets for DocuSign's stock. Their DOCU share price targets range from $42.00 to $87.00. On average, they expect the company's stock price to reach $60.00 in the next year. This suggests a possible upside of 12.6% from the stock's current price.
View analysts price targets for DOCU
or view top-rated stocks among Wall Street analysts.

How have DOCU shares performed in 2024?

DocuSign's stock was trading at $59.45 at the start of the year. Since then, DOCU shares have decreased by 10.4% and is now trading at $53.27.
View the best growth stocks for 2024 here
.

Are investors shorting DocuSign?

DocuSign saw a decrease in short interest during the month of February. As of February 15th, there was short interest totaling 4,730,000 shares, a decrease of 7.3% from the January 31st total of 5,100,000 shares. Based on an average trading volume of 4,920,000 shares, the short-interest ratio is currently 1.0 days.
View DocuSign's Short Interest
.

When is DocuSign's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 7th 2024.
View our DOCU earnings forecast
.

How can I listen to DocuSign's earnings call?

DocuSign will be holding an earnings conference call on Thursday, March 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13743590".

How were DocuSign's earnings last quarter?

DocuSign, Inc. (NASDAQ:DOCU) posted its quarterly earnings results on Thursday, December, 7th. The company reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.16. The business earned $700.42 million during the quarter, compared to the consensus estimate of $690.27 million. DocuSign had a trailing twelve-month return on equity of 14.06% and a net margin of 1.90%. DocuSign's revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.05 EPS.

What guidance has DocuSign issued on next quarter's earnings?

DocuSign issued an update on its fourth quarter 2024 earnings guidance on Monday, December, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $696.0 million-$700.0 million, compared to the consensus revenue estimate of $693.7 million.

What is Daniel Springer's approval rating as DocuSign's CEO?

782 employees have rated DocuSign Chief Executive Officer Daniel Springer on Glassdoor.com. Daniel Springer has an approval rating of 98% among the company's employees. This puts Daniel Springer in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of DocuSign own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DocuSign investors own include NVIDIA (NVDA), Block (SQ), Tesla (TSLA), Advanced Micro Devices (AMD), Zoom Video Communications (ZM), PayPal (PYPL), Salesforce (CRM), Alibaba Group (BABA), Shopify (SHOP) and Netflix (NFLX).

When did DocuSign IPO?

(DOCU) raised $542 million in an initial public offering on Friday, April 27th 2018. The company issued 21,700,000 shares at $24.00-$26.00 per share. Morgan Stanley and J.P. Morgan acted as the underwriters for the IPO and Citigroup, BofA Merrill Lynch, Deutsche Bank Securities, JMP Securities, Pper Jaffray and William Blair were co-managers.

Who are DocuSign's major shareholders?

DocuSign's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.49%), Price T Rowe Associates Inc. MD (3.92%), Coatue Management LLC (2.38%), Capital International Investors (1.34%), Clearbridge Investments LLC (1.30%) and Norges Bank (1.10%). Insiders that own company stock include Allan C Thygesen, Blake Jeffrey Grayson, Cynthia Gaylor, Daniel D Springer, Enrique T Salem, Enrique T Salem, James P Shaughnessy, Loren Alhadeff, Peter Solvik, Scott V Olrich, Stephen Shute, Teresa Briggs and Tram T Phi.
View institutional ownership trends
.

How do I buy shares of DocuSign?

Shares of DOCU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DOCU) was last updated on 3/1/2024 by MarketBeat.com Staff